
Jaime Libes
Physician · Orlando Health
Credentials: · · · · · ·
History
- 2024–Present
- 2011–2012
2008–2011George Washington University’s School
Research
Risk factors for abandonment of Wilms tumor therapy in Kenya
Pediatric Blood & Cancer · 2015 · First of 14 authors · 37 citations
Pediatric renal tumor epidemiology: Global perspectives, progress, and challenges
Review · Pediatric Blood & Cancer · 2023 · First of 9 authors · 23 citations
Race disparities in peptide profiles of North American and Kenyan Wilms tumor specimens
Journal of the American College of Surgeons · 2014 · First of 16 authors · 21 citations

6 papers

3 papers

3 papers

3 papers

3 papers · 3 as a fellow

2 papers · 2 as a resident

2 papers

2 papers
Clinical trials
- 2025–2029
Site PI · Recruiting · Phase 3
Children's Oncology Group
- 2024–2035
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Site PI · Recruiting · Phase 1, Phase 2
Milton S. Hershey Medical Center
- 2024–2027
Site PI · Recruiting · Phase 2
Children's Oncology Group
- 2022–2036
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Site PI · Recruiting · Phase 2
Giselle Sholler

